z-logo
open-access-imgOpen Access
Adverse Events (AE) and Laboratory Changes in a Real-World Population of Hepatitis C Virus (HCV)-Infected Patients With Chronic Kidney Disease (CKD) Treated With Sofosbuvir (SOF)-Based Therapy
Author(s) -
Elke Backman,
Guillermo Ortiz,
Gregory L. Hundemer,
Nneka N. Ufere,
Raymond T. Chung,
Meghan E. Sise
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.744
Subject(s) - medicine , sofosbuvir , hepatitis c virus , kidney disease , adverse effect , virology , virus , disease , hepatitis c , population , rescue therapy , intensive care medicine , immunology , ribavirin , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom